Investigation of the involvement of MIR185 and its target genes in the development of schizophrenia

Journal of Psychiatry and Neuroscience

Volumn 39, Issue 6, 2014, Pages 386-396

  Forstner, Andreas J ^a,b   Buket Basmanav, F ^a,b   Mattheisen, Manuel ^a,c,d   Böhmer, Anne C ^a,b   Hollegaard, Mads V ^e   Janson, Esther ^f   Strengman, Eric ^f   Priebe, Lutz ^a,b   Degenhardt, Franziska ^a,b   Hoffmann, Per ^a,b,g   Herms, Stefan ^a,b,g   Maier, Wolfgang ^a   Mössner, Rainald ^a   Rujescu, Dan ^h   Ophoff, Roel A ^i,j   Moebus, Susanne ^k   Mortensen, Preben B ^c,d   Børglum, Anders D ^c,d,l   Hougaard, David M ^e   Frank, Josef ^m   Witt, Steanie H ^m   Rietschel, Marcella ^m   Zimmer, Andreas ^a   Nöthen, Markus M ^a,b   Miró, Xavier ^a   Cichon, Sven ^a,b,g,n   more..

^a UNIVERSITY OF BONN   (Germany)

^b Life and Brain Center   (Germany)

^c AARHUS UNIVERSITY   (Denmark)

^d H LUNDBECK A S   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k UNIVERSITY OF DUISBURG ESSEN   (Germany)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m UNIVERSITY OF HEIDELBERG   (Germany)

ⁿ FORSCHUNGSZENTRUM JÜLICH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MICRORNA; MICRORNA 185; UNCLASSIFIED DRUG; 3-DECYL-1,5,8-TRIAZACYCLODECANE-2,4-DIONE; ACYLTRANSFERASE; ALPHA-TUBULIN ACETYLTRANSFERASE 1, MOUSE; HETEROCYCLIC COMPOUND; MIRN185 MICRORNA, HUMAN; MIRN185 MICRORNA, MOUSE; NEUROTROPHIN 3 RECEPTOR;

ADULT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EMBRYO; FEMALE; GENE EXPRESSION; GENE MAPPING; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BRAIN; C57BL MOUSE; CAUCASIAN; EMBRYOLOGY; GENETIC VARIABILITY; GENETICS; GENOTYPING TECHNIQUE; METABOLISM;

ACETYLTRANSFERASES; ANIMALS; BRAIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; HETEROCYCLIC COMPOUNDS; HUMANS; IN SITU HYBRIDIZATION; MICE, INBRED C57BL; MICRORNAS; RECEPTOR, TRKC; SCHIZOPHRENIA;

EID: 84907688526     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130189     Document Type: Article

References (60)

1. Insel TR. Rethinking schizophrenia. Nature 2010;468:187-93.
2. Levinson DF, Duan J, Oh S, et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011;168:302-16.
3. Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 2010;11:402-16.
4. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999;56:940-5.
5. Bassett AS, Chow EW. Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 2008;10:148-57.
6. Earls LR, Fricke RG, Yu J, et al. Age-Dependent MicroRNA Control of Synaptic Plasticity in 22q11 Deletion Syndrome and Schizophrenia. J Neurosci 2012;32:14132-44.
7. Edelmann L, Pandita RK, Morrow BE. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet 1999;64:1076-86.
8. Shaikh TH, Kurahashi H, Saitta SC, et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 2000;9:489-501.
9. Fineberg SK, Kosik KS, Davidson BL. MicroRNAs potentiate neural development. Neuron 2009;64:303-9.
10. Schratt G. microRNAs at the synapse. Nat Rev Neurosci 2009;10:842-9.
11. Xu B, Karayiorgou M, Gogos JA. MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Res 2010;1338:78-88.
12. Beveridge NJ, Tooney PA, Carroll AP, et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet 2008;17:1156-68.
13. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011;43:969-76.
14. Stark KL, Xu B, Bagchi A, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 2008;40:751-60.
15. Benetti S, Mechelli A, Picchioni M, et al. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain 2009;132:2426-36.
16. Xu B, Hsu PK, Stark KL, et al. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell 2013;152:262-75.
17. Liu M, Lang N, Chen X, et al. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett 2011;301:151-60.
18. Hill JJ, Hashimoto T, Lewis DA. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2006;11:557-66.
19. Ide M, Lewis DA. Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol Psychiatry 2010;68:25-32.
20. Nelson PT, Wilfred BR. In situ hybridization is a necessary experimental complement to microRNA (miRNA) expression profiling in the human brain. Neurosci Lett 2009;466:69-72.
21. Miró X, Zhou X, Boretius S, et al. Haploinsufficiency of the murine polycomb gene Suz12 results in diverse malformations of the brain and neural tube. Dis Model Mech 2009;2:412-8.
22. Diez-Roux G, Banfi S, Sultan M, et al. A high-resolution anatomical atlas of the transcriptome in the mouse embryo. PLoS Biol 2011;9:e1000582.
23. Lein ES, Hawrylycz MJ, Ao N, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007;445:168-76.
24. Børglum AD, Demontis D, Grove J, et al. Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry 2014;19:325-33.
25. Pedroso I, Lourdusamy A, Rietschel M, et al. Common genetic variants and gene-expression changes associated with bipolar disorder are over-represented in brain signaling pathway genes. Biol Psychiatry 2012;72:311-7.
26. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50.
27. Treutlein J, Cichon S, Ridinger M, et al. Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 2009;66:773-84.
28. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008;455:232-6.
29. Colella S, Yau C, Taylor JM, et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 2007;35:2013-25.
30. Kent WJ, Sugnet CW, Furey TS, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
31. Pruitt KD, Tatusova T, Klimke W, et al. NCBI reference sequences: current status, policy and new initiatives. Nucleic Acids Res 2009; 37:D32-6.
32. Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56-65.
33. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000;15:7-12.
34. Desmet FO, Hamroun D, Lalande M, et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009;37:e67.
35. Schmermund A, Mohlenkamp S, Stang A, et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am Heart J 2002;144:212-8.
36. Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry 2010;167:1178-93.
37. Olenik C, Barth H, Just I, et al. Gene expression of the small GTP-binding proteins RhoA, RhoB, Rac1, and Cdc42 in adult rat brain. Brain Res Mol Brain Res 1997;52:263-9.
38. Chow EW, Mikulis DJ, Zipursky RB, et al. Qualitative MRI findings in adults with 22q11 deletion syndrome and schizophrenia. Biol Psychiatry 1999;46:1436-42.
39. Gerkes EH, Hordijk R, Dijkhuizen T, et al. Bilateral polymicrogyria as the indicative feature in a child with a 22q11.2 deletion. Eur J Med Genet 2010;53:344-6.
40. Koolen DA, Veltman JA, Renier WO, et al. Chromosome 22q11 deletion and pachygyria characterized by array-based comparative genomic hybridization. Am J Med Genet A 2004;131:322-4.
41. Robin NH, Taylor CJ, McDonald-McGinn DM, et al. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A 2006;140:2416-25.
42. Lynch DR, McDonald-McGinn DM, Zackai EH, et al. Cerebellar atrophy in a patient with velocardiofacial syndrome. J Med Genet 1995;32:561-3.
43. Gamazon ER, Ziliak D, Im HK, et al. Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet 2012;90:1046-63.
44. Shida T, Cueva JG, Xu Z, et al. The major alpha-tubulin K40 acetyltransferase alphaTAT1 promotes rapid ciliogenesis and efficient mechanosensation. Proc Natl Acad Sci U S A 2010;107:21517-22.
45. Li L, Wei D, Wang Q, et al. MEC-17 deficiency leads to reduced alpha-tubulin acetylation and impaired migration of cortical neurons. J Neurosci 2012;32:12673-83.
46. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009;460:748-52.
47. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009;460:753-7.
48. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature 2009;460:744-7.
49. Courtneidge SA. Cell migration and invasion in human disease: the Tks adaptor proteins. Biochem Soc Trans 2012;40:129-32.
50. Murphy DA, Diaz B, Bromann PA, et al. A Src-Tks5 pathway is required for neural crest cell migration during embryonic development. PLoS ONE 2011;6:e22499.
51. Owen MJ, O'Donovan MC, Thapar A, et al. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 2011;198:173-5.
52. Lamballe F, Smeyne RJ, Barbacid M. Developmental expression of trkC, the neurotrophin-3 receptor, in the mammalian nervous system. J Neurosci 1994;14:14-28.
53. Schramm M, Falkai P, Feldmann N, et al. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia. Neurosci Lett 1998;257:65-8.
54. Weickert CS, Ligons DL, Romanczyk T, et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2005;10:637-50.
55. Athanasiu L, Mattingsdal M, Melle I, et al. Intron 12 in NTRK3 is associated with bipolar disorder. Psychiatry Res 2011;185:358-62.
56. Otnaess MK, Djurovic S, Rimol LM, et al. Evidence for a possible association of neurotrophin receptor (NTRK-3) gene polymorphisms with hippocampal function and schizophrenia. Neurobiol Dis 2009;34:518-24.
57. Guo L, Lu Z. The fate of miRNA* strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule? PLoS ONE 2010;5:e11387.
58. Hildebrand MS, Witmer PD, Xu S, et al. miRNA mutations are not a common cause of deafness. Am J Med Genet A 2010;152A:646-52.
59. Williams NM. Molecular mechanisms in 22q11 deletion syndrome. Schizophr Bull 2011;37:882-9.
60. Bansal V, Libiger O, Torkamani A, et al. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010;11:773-85.